Validation of RespiLife for Detection of Respiratory Suppression

Validation of RespiLife for Detection of Respiratory Suppression

The purpose of this study is to evaluate the accuracy of RespiLife diagnostic technology for detection of respiratory rate and oxygen saturation in human subjects. This includes evaluation of Bioresp's RespiLife and its accuracy for measurement of respiratory rate and oxygen saturation.

The purpose of this study is to evaluate the accuracy of RespiLife diagnostic technology for detection of respiratory rate and oxygen saturation in human subjects. This includes evaluation of Bioresp's RespiLife and its accuracy for measurement of respiratory rate and oxygen saturation.

Inclusion Criteria:

• Able to understand and sign the informed consent
• English speaking.
• Able to comply with visits and follow ups included in this protocol
• Ages 18-80 years

Exclusion Criteria:

• Mentally or cognitively incompetent persons who cannot understand the procedures or consent to the procedures.
• An unstable medical condition, acute of chronic, that in the opinion of the investigator puts the subject at health risks related this trial or interferes with the clinical trial and data collection.
• If a subject is not able to stop his CPAP or BiPAP therapy at least one week prior to the sleep study night. This will be determined ty the principal investigator based on her judgment.
• Skin rash on the forehead.
• A history of skin allergy to medical tape, even hypoallergenic tape.
• A history of skin cancer on the forehead.